Interferon and prednisone therapy in chronic hepatitis C with non-organ-specific antibodies
References (27)
- et al.
Cutaneous vasculitis and cryoglobulinaemia type 2 associated with hepatitis C infection
Lancet
(1991) - et al.
Lymphocytic sialoadenitis of Sjögren's syndrome associated with chronic hepatitis C virus liver disease
Lancet
(1992) - et al.
Rapidly progressive non A-non B hepatitis in patients with human immunodeficiency virus infection
Gastroenterology
(1989) - et al.
Short-term prednisone therapy affects aminotransferase activity and hepatitis C virus RNA levels in chronic hepatitis C
Gastroenterology
(1994) - et al.
Acute exacerbation of liver disease during interferon alpha therapy for chronic hepatitis C
Gastroenterology
(1992) - et al.
Type 2 autoimmune hepatitis and hepatitis C virus infection
Lancet
(1990) - et al.
Interferon therapy in liver-kidney microsomal antibody type 1 positive patients with chronic hepatitis C
J Hepatol
(1994) - et al.
Antibodies to C virus in autoimmune liver disease: evidence for geographical heterogeneity
Lancet
(1991) - et al.
High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C
Hepatology
(1995) - et al.
Characterization of anti-liver kidney microsome antibody from hepatitis C virus-positive and negative sera
Gastroenterology
(1993)
A role for hepatitis C virus infection in type II cryoglobulinemia
N Engl J Med
(1992)
Immunological disorders in C virus chronic active hepatitis: a prospective case-control study
Hepatology
(1994)
Membranoproliferative glomerulonephritis associated with hepatitis C virus infection
N Engl J Med
(1993)
Cited by (57)
The safety of omalizumab therapy in a patient with severe persistent allergic asthma and hepatitis C
2009, Annals of Allergy, Asthma and ImmunologyLate Complications of Liver Transplantation and Recurrence of Disease
2005, Transplantation of the LiverLiver biopsy, viral kinetics, and the impact of viremia on severity of hepatitis C virus recurrence
2003, Liver TransplantationHistological improvement in chronic hepatitis C-autoimmune hepatitis overlap syndrome by glecaprevir and pibrentasvir
2023, Clinical Journal of GastroenterologyDirect acting antiviral therapy is curative for chronic hepatitis C/autoimmune hepatitis overlap syndrome
2016, World Journal of HepatologyAutoantibodies in chronic hepatitis C: A clinical perspective
2015, World Journal of Hepatology
Copyright © 1996 Published by Elsevier Ireland Ltd.